Variant-based heritability assessment of dexmedetomidine and fentanyl clearance in pediatric patients.
Ontology highlight
ABSTRACT: Despite complex pathways of drug disposition, clinical pharmacogenetic predictors currently rely on only a few high effect variants. Quantification of the polygenic contribution to variability in drug disposition is necessary to prioritize target drugs for pharmacogenomic approaches and guide analytic methods. Dexmedetomidine and fentanyl, often used in postoperative care of pediatric patients, have high rates of inter-individual variability in dosing requirements. Analyzing previously generated population pharmacokinetic parameters, we used Bayesian hierarchical mixed modeling to measure narrow-sense (additive) heritability ( hSNP2 ) of dexmedetomidine and fentanyl clearance in children and identify relative contributions of small, moderate, and large effect-size variants to hSNP2 . We us
SUBMITTER: Shannon ML
PROVIDER: S-EPMC10499425 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA